Thomas Pålsson

Thomas is a CFO Consultant with more than 20 years of experience within Life Science start-up companies including Arexis AB, merged into Swedish Orphan Biovitrum AB (publ), Pharmasurgics AB, merged into Promore Pharma AB (publ), and Integrum AB (publ). He has also spent 10 years as CFO/Business Controller in Albireo AB (associated company to AstraZeneca) listed at Nasdaq Composite in New York.